-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Integra Lifesciences Holdings Corp annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Integra Lifesciences Holdings Corp annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$19.1M, a 64.4% decline from 2022.
- Integra Lifesciences Holdings Corp annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$11.6M, a 9.66% increase from 2021.
- Integra Lifesciences Holdings Corp annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$12.8M, a 153% decline from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)